It can be hard to find a doctor who knows what myositis is and how to treat it. This tool can help.
Continue Reading
New Year’s Non-resolutions
Does the idea of New Year Resolutions stress you out? Here are some alternatives to this tradition that can add value to your year ahead without adding extra pressure.
Continue Reading
Vamorolone approved by FDA
Recently, the FDA announced the approval of a new drug, vamorolone, as a treatment for Duchenne muscular dystrophy (DMD), a genetic muscle disease that usually affects young boys. Understandably, this news hasn’t made a big splash in myositis circles, but it should. Vamorolone, marketed under the name Agamree, is a corticosteroid drug with a twist….
Continue Reading
IBM patients battle for veterans benefits
Recently, two members of TMA’s Military Veterans with Myositis Affinity Group were successful in acquiring disability benefits from the Veterans Administration. These benefits are significant. Not only are these former service members eligible to receive complete healthcare services and disability compensation, they can also access important benefits such as a travel allowance for medical appointments,…
Continue Reading
Paula Eichenbrenner joins TMA
Starting November 29, 2023, TMA will have a new executive director. After a months-long national search, TMA’s Board of Directors has found the perfect candidate to serve as TMA’s executive director. “We couldn’t be more delighted to welcome Paula Eichenbrenner to TMA,” says Board of Directors Chair Dave Mochel. “She possesses not just the business…
Continue Reading